Allegra coated tablets 120 mg, # 10
Dosage:
120mg
180mg
Category
Allergy
Scope of the drug
Leather
,
Dermatology
,
Ear, Throat, Nose
Release form
Tablet
Manufacturer country
France
Package quantity, pcs
ten
Allegra tab.
p / o captivity.
120 mg No. 10
Name ENG
ALLEGRA
Clinical and pharmacological group
Blocker of histamine H1 receptors.
Antiallergic drug
ATX code
Fexofenadine
Dosage
120mg
Structure
Light pink film-coated tablets, oblong, biconvex, engraved with 012" on one side and stylized "e" on the other.
.Auxiliary substances: croscarmellose sodium - 24 mg, pregelatinized starch - 120 mg, microcrystalline cellulose - 133 mg, magnesium stearate - 3 mg.
The composition of the shell: hypromellose E-15 - 2.84 mg, hypromellose E-5 - 1.89 mg, povidone - 510 μg, titanium dioxide (E171) - 2.025 mg, colloidal silicon dioxide - 730 μg, macrogol 400 - 3.94 mg, pink mixture of dye iron oxide (iron oxide red (E172), titanium dioxide (E171)) - 250 μg, yellow mixture of iron dye (iron oxide yellow (E172), titanium dioxide (E171)) - 40 μg.
Indications
Seasonal allergic rhinitis (for symptom relief) - 120 mg tablet
chronic idiopathic urticaria (to reduce symptoms) - tablets, 180 mg.
Contraindications
Hypersensitivity to any component of the drug
pregnancy
lactation period
children's age (up to 12 years old).
With care: in patients with chronic renal and hepatic insufficiency, as well as in elderly patients (lack of clinical experience in this category of patients)
in patients with cardiovascular diseases, including a history (antihistamines can cause palpitations and tachycardia).
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 3 years
INN / Active ingredient
Fexofenadine
Specifications
Category
Allergy
Scope of the drug
Leather
,
Dermatology
,
Ear, Throat, Nose
Release form
Tablet
Manufacturer country
France
Package quantity, pcs
ten
Scope of application
Allergology
,
Dermatology
Minimum age from
12 years
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Sanofi
The amount of the dosage form in the primary package
10 pieces.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
R06AX26 Fexofenadine
Dosage form
Film-coated tablets
The target audience
Children
Expiration date in days
1095
Dosage (volume) of the substance in the preparation
fexofenadine hydrochloride 120 mg
Package weight, g
35
Mode of application
:
The tablets are intended for oral administration.
< br> The recommended dose of fexofenadine for chronic urticaria for adults and children 12 years and older is 180 mg once a day before meals.
< br> Patients at risk
< br> Studies in special risk groups (elderly patients, patients with renal and hepatic insufficiency) have shown that they do not need to adjust the dosage regimen.
Pharmaco-therapeutic group
:
Antiallergic agent - H1-histamine receptor blocker
"